Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis

被引：65
|
作者：
Müller, FMC
Weig, M
Peter, J
Walsh, TJ
机构：
[1] Univ Wurzburg, Univ Kinderklin, D-97080 Wurzburg, Germany
[2] NCI, Immunocompromised Host Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA
[3] Univ Wurzburg, Inst Mol Infekt Biol, D-97080 Wurzburg, Germany
[4] Univ Wurzburg, Inst Hyg & Mikrobiol, Wurzburg, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2000年 / 46卷 / 02期
关键词：
D O I：
10.1093/jac/46.2.338
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：338 / 341
页数：4
相关论文
共 50 条
  • [1] Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
    Martínez, M
    López-Ribot, JL
    Kirkpatrick, WR
    Bachmann, SP
    Perea, S
    Ruesga, MT
    Patterson, TF
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) : 515 - 524
  • [2] Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis
    Barchiesi, F
    Arzeni, D
    Del Prete, MS
    Sinicco, A
    Di Francesco, LF
    Pasticci, MB
    Lamura, L
    Nuzzo, MM
    Burzacchini, F
    Coppola, S
    Chiodo, F
    Scalise, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) : 541 - 548
  • [3] Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis
    Salari, S.
    Khosravi, A. R.
    Mousavi, S. A. A.
    Nikbakht-Brojeni, G. H.
    [J]. JOURNAL DE MYCOLOGIE MEDICALE, 2016, 26 (01): : 35 - 41
  • [4] Parallel- and cross-resistance of the azoles fluconazole, itraconazole, kezoconazole, voriconazole, and of fluconazole to clinical yeast isolates
    Schmalreck, A. F.
    Becker, K.
    Fegeler, W.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S562 - S563
  • [5] Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil
    Goldman, GH
    Ferreira, MED
    Marques, ED
    Savoldi, M
    Perlin, D
    Park, S
    Martinez, PCG
    Goldman, MHS
    Colombo, AL
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) : 25 - 32
  • [6] Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis (vol 41, pg 541, 1998)
    Barchiesi, F
    Arzeni, D
    Del Prete, MS
    Sinicco, A
    Di Francesco, LF
    Pasticci, MB
    Lamura, L
    Nuzzo, MM
    Burzacchini, F
    Coppola, S
    Chiodo, F
    Scalise, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (03) : 413 - 413
  • [7] MOLECULAR CHARACTERIZATION OF AZOLE RESISTANCE MECHANISMS IN CANDIDA ALBICANS CLINICAL ISOLATES FROM HIV-INFECTED PATIENTS IN INDIA
    Singh, Desh D.
    Khare, Mayuri
    Singh, Vinod
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (09): : 3924 - 3931
  • [8] Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis
    Cartledge, JD
    Midgley, J
    Gazzard, BG
    [J]. AIDS, 1997, 11 (15) : 1839 - 1844
  • [9] FLUCONAZOLE VERSUS KETOCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED CHILDREN
    HERNANDEZSAMPELAYO, T
    ROBERTS, A
    TRICOIRE, J
    GIBB, DM
    HOLZEL, H
    NOVELLI, VM
    DEJOSE, MI
    PEREZGORRICHO, B
    FORTUNYGUASCH, C
    MURSIERRA, A
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (04) : 340 - 344
  • [10] Itraconazole suspension in the treatment of HIV-infected patients suffering from fluconazole-resistant oropharyngeal and oesophageal candidosis
    Eichel, M
    JustNubling, G
    Helm, EB
    Stille, W
    [J]. MYCOSES, 1996, 39 : 102 - 106
12345